Home » Topics » Regulatory » Patents

Patents
RSS

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

New agents for cancer discovered at Zeneca

Jan. 19, 1998

Novel CNS agents disclosed by HMR

Jan. 19, 1998

More dopaminergic agents in the pipeline at Neurogen

Jan. 19, 1998

New therapeutic tetrahydrofuran derivatives from Janssen

Jan. 19, 1998

U. of Mass. scientists design anti-EBV antisense oligonucleotides

Jan. 16, 1998

Lilly claims another series of heterocyclic muscarinic receptor modulators

Jan. 16, 1998

Takeda discloses compounds for cachexia

Jan. 16, 1998

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

Inhibitors of iNOS developed at Astra

Jan. 16, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...